{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:56:21Z","timestamp":1788666981087,"version":"build-2803163510"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,15]]},"DOI":"10.1093\/infdis\/jis771","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T04:57:30Z","timestamp":1355893050000},"page":"1016-1025","source":"Crossref","is-referenced-by-count":67,"title":["Successful Therapy of Visceral Leishmaniasis With Curdlan Involves T-Helper 17 Cytokines"],"prefix":"10.1093","volume":"207","author":[{"given":"Kuntal","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanta","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pijush K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindita","family":"Ukil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"key\n\t\t\t\t20170702130043_JIS771C1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1126\/science.284.5416.951","article-title":"Requirement for type 2 NO synthase for IL-12 signaling in innate immunity","volume":"284","author":"Diefenbach","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t20170702130043_JIS771C2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N","article-title":"Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani","volume":"28","author":"Engwerda","year":"1998","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C3","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170702130043_JIS771C4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.0204065","article-title":"Interleukin-17 regulates expression of the CXC chemokine LIX\/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment","volume":"76","author":"Ruddy","year":"2004","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C5","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","article-title":"Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways","volume":"162","author":"Laan","year":"1999","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.4049\/jimmunol.0801599","article-title":"TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection","volume":"183","author":"Loures","year":"2009","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/IAI.73.1.617-621.2005","article-title":"Interleukin-17\/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection","volume":"73","author":"Kelly","year":"2005","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170702130043_JIS771C9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170702130043_JIS771C10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20170702130043_JIS771C11","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev-physiol-021909-135926","article-title":"TH17 cells in asthma and COPD","volume":"72","author":"Alcorn","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.smim.2007.10.012","article-title":"The link between IL-23 and Th17 cell-mediated immune pathologies","volume":"19","author":"McGeachy","year":"2007","journal-title":"Semin Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C14","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170702130043_JIS771C15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/viru.1.5.12862","article-title":"IL-17 in protective immunity to intracellular pathogens","volume":"1","author":"Khader","year":"2010","journal-title":"Virulence"},{"key":"key\n\t\t\t\t20170702130043_JIS771C16","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/IAI.05493-11","article-title":"Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection","volume":"79","author":"Werner","year":"2011","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170702130043_JIS771C17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0144-8617(95)00076-3","article-title":"(1\u21923)-\u03b2-D-Glucans as biological response modifiers: a review of structure-functional activity","volume":"28","author":"BeMiller","year":"1995","journal-title":"Carbohydr Polym"},{"key":"key\n\t\t\t\t20170702130043_JIS771C18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0162-3109(99)00013-2","article-title":"Therapeutic intervention with complement and beta-glucan in cancer","volume":"42","author":"Ross","year":"1999","journal-title":"Immunopharmacology"},{"key":"key\n\t\t\t\t20170702130043_JIS771C19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-065X.2009.00793.x","article-title":"Beta-glucan recognition by the innate immune system","volume":"230","author":"Goodridge","year":"2009","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20170702130043_JIS771C20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1189\/jlb.1206753","article-title":"The role of the beta-glucan receptor dectin-1 in control of fungal infection","volume":"82","author":"Dennehy","year":"2007","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C21","doi-asserted-by":"crossref","first-page":"e13418","DOI":"10.1371\/journal.pone.0013418","article-title":"Human dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses","volume":"5","author":"Agrawal","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170702130043_JIS771C22","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/382048","article-title":"Targeting of parasite-specific immunoliposome-encapsulated doxorubicin in the treatment of experimental visceral leishmaniasis","volume":"189","author":"Mukherjee","year":"2004","journal-title":"J Infec Dis"},{"key":"key\n\t\t\t\t20170702130043_JIS771C23","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/AAC.41.5.1064","article-title":"Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes","volume":"41","author":"Ephros","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170702130043_JIS771C24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4049\/jimmunol.151.2.929","article-title":"Role and effect of IL-2 in experimental visceral leishmaniasis","volume":"151","author":"Murray","year":"1993","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C25","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4049\/jimmunol.181.2.1386","article-title":"Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses","volume":"181","author":"Banerjee","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4049\/jimmunol.175.2.1161","article-title":"18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B","volume":"175","author":"Ukil","year":"2005","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C27","doi-asserted-by":"crossref","first-page":"e29062","DOI":"10.1371\/journal.pone.0029062","article-title":"Curative effect of 18beta-glycyrrhetinic acid in experimental visceral leishmaniasis depends on phosphatase-dependent modulation of cellular MAP kinases","volume":"6","author":"Ukil","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170702130043_JIS771C28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.0909644","article-title":"MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms","volume":"88","author":"Kar","year":"2010","journal-title":"J Leukoc Biol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C29","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1462-5822.2008.01188.x","article-title":"Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages","volume":"10","author":"Ferwerda","year":"2008","journal-title":"Cell Microbiol"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170702130043_JIS771C30","first-page":"S7","article-title":"Immunomodulators: current and future development and application","volume":"19","author":"Chirigos","year":"1992","journal-title":"Thymus"},{"key":"key\n\t\t\t\t20170702130043_JIS771C31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jac\/dkn479","article-title":"Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity","volume":"63","author":"Bhattacharjee","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170702130043_JIS771C32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1382-6689(98)00011-8","article-title":"(1\u21923)-beta-d-Glucan stimulates nitric oxide generation and cytokine mRNA expression in macrophages","volume":"5","author":"Ljungman","year":"1998","journal-title":"Environ Toxicol Pharmacol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0035-9203(98)90969-5","article-title":"The effect of curdlan sulphate on development in vitro of Plasmodium falciparum","volume":"92","author":"Evans","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702130043_JIS771C34","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/viro.1994.1395","article-title":"Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro","volume":"202","author":"Jagodzinski","year":"1994","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702130043_JIS771C35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/AAC.40.1.253","article-title":"Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway","volume":"40","author":"Vouldoukis","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170702130043_JIS771C36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.it.2011.08.003","article-title":"Deciphering the role of Th17 cells in human disease","volume":"32","author":"Wilke","year":"2011","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C37","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1172\/JCI44999","article-title":"The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A","volume":"121","author":"Moreira","year":"2011","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170702130043_JIS771C38","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C39","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170702130043_JIS771C40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20170702130043_JIS771C41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170702130043_JIS771C42","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1084\/jem.20090900","article-title":"Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrix metalloproteinase-2 and IL-22 but independent of IL-17","volume":"206","author":"Munoz","year":"2009","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20170702130043_JIS771C43","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C44","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/eji.201041056","article-title":"c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection","volume":"41","author":"Reinhard","year":"2011","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20170702130043_JIS771C45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","article-title":"Interleukin-23: as a drug target for autoimmune inflammatory diseases","volume":"135","author":"Tang","year":"2012","journal-title":"Immunology"},{"key":"key\n\t\t\t\t20170702130043_JIS771C46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11010-011-1109-6","article-title":"Interleukin-23 as a potential therapeutic target for rheumatoid arthritis","volume":"361","author":"Rong","year":"2012","journal-title":"Mol Cell Biochem"},{"key":"key\n\t\t\t\t20170702130043_JIS771C47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/13543784.2012.669372","article-title":"Current investigational drugs in psoriasis","volume":"21","author":"Ryan","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20170702130043_JIS771C48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/207\/6\/1016\/18068323\/jis771.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:19:17Z","timestamp":1714749557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jis771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,12,18]]},"published-print":{"date-parts":[[2013,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jis771","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}